FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Juha Rinne

Research Profile

Disorders

Procedures

Anatomy

Chemicals & Drugs

Concepts & Ideas

Neuropsychological Tests

Co-author Network

Publications

TOP 3
Pekka Jokinen; Mira Karrasch; Jörgen Bergman; Anna Brück; Jarkko Johansson; Juha O Rinne
Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
Lisa Mosconi; John Murray; Kjell Någren; Elizabeth Pirraglia; Juha O Rinne; Noora Scheinin; Wai Hon Tsui; Shankar Vallabhajosula; Tapio Viljanen; Schantel Williams; Lidia Glodzik; Stanley J Goldsmith; Yi Li; Pauline McHugh; Megan Cummings; Mony J de Leon
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
Juha O Rinne; Paul F Sherwin; Adrian Smith; David A Wolk; Dean F Wong; Steven E Arnold; Chris Buckley; Gill Farrar; Marita Kailajärvi; Ville Leinonen; Richard McLain; Igor D Grachev
[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Juha Rinne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pekka Jokinen; Mira Karrasch; Jörgen Bergman; Anna Brück; Jarkko Johansson; Juha O Rinne
Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
Journal of the neurological sciences 2013;329(1-2):23-8.
2013: Lisa Mosconi; John Murray; Kjell Någren; Elizabeth Pirraglia; Juha O Rinne; Noora Scheinin; Wai Hon Tsui; Shankar Vallabhajosula; Tapio Viljanen; Schantel Williams; Lidia Glodzik; Stanley J Goldsmith; Yi Li; Pauline McHugh; Megan Cummings; Mony J de Leon
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
Neurobiology of aging 2013;34(1):22-34.
2012: Juha O Rinne; Paul F Sherwin; Adrian Smith; David A Wolk; Dean F Wong; Steven E Arnold; Chris Buckley; Gill Farrar; Marita Kailajärvi; Ville Leinonen; Richard McLain; Igor D Grachev
[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
Acta neuropathologica 2012;124(6):833-45.
2012: Valtteri Kaasinen; Olli Eskola; Pekka Jokinen; Juho Joutsa; Juha O Rinne
Seasonality of striatal dopamine synthesis capacity in Parkinson's disease.
Neuroscience letters 2012;530(1):80-4.
2012: Anniina Snellman; Olof Solin; Ian Wilson; Olli Eskola; Gill Farrar; Francisco R Lopez-Picon; Juha O Rinne; Johanna Rokka; Mika Scheinin; Merja Haaparanta-Solin
Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
European journal of nuclear medicine and molecular imaging 2012;39(11):1784-95.
2012: Kaj Blennow; Michael Grundman; Enchi Liu; Juha O Rinne; Stephen Salloway; Jenny Wei; Henrik Zetterberg; Ronald Black
Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.
Archives of neurology 2012;69(8):1002-10.
2012: Roongroj Bhidayasiri; Chanisa Chotipanich; Jarkko Johansson; Juho Joutsa; Wantana Juiklom; Supatporn Tepmongkol; Natnipa Wannachai; Juha O Rinne
Boxing and Parkinson disease: a link or a myth? An 18F-FDOPA PET/CT study in retired Thai traditional boxers.
Parkinsonism & related disorders 2012;18(5):694-6.
2012: Juho Joutsa; Sarita Forsback; Jarkko Johansson; Kirsti Martikainen; Solja Niemelä; Juha O Rinne; Valtteri Kaasinen
Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders.
Movement disorders : official journal of the Movement Disorder Society 2012;27(6):778-82.
2012: Juho Joutsa; Hannu Alho; Eveliina Arponen; Jarmo Hietala; Mika M Hirvonen; Jarkko Johansson; Solja Niemelä; Antti Ollikainen; Petteri Piepponen; Juha O Rinne; Valerie Voon; Valtteri Kaasinen
Mesolimbic dopamine release is linked to symptom severity in pathological gambling.
NeuroImage 2012;60(4):1992-9.
2012: Myoung Soo Kwon; Matti Laine; Harri Lindholm; Juha O Rinne; Mika Teräs; Tommi Toivonen; Lauri Tuominen; Victor A Vorobyev; Tommi Alanko; Jarkko Johansson; Juho Joutsa; Sami Kännälä; Heikki Hämäläinen
No effects of short-term GSM mobile phone radiation on cerebral blood flow measured using positron emission tomography.
Bioelectromagnetics 2012;33(3):247-56.
2012: Jussi Koivunen; Kjell Någren; Sargo Aalto; Semi Helin; Mira Karrasch; Noora M Scheinin; Tero Vahlberg; Matti Viitanen; Juha O Rinne
Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.
Dementia and geriatric cognitive disorders 2012;34(1):31-7.
2012: Alessandra Marcone; Rosa Maria Moresco; Alessandro Padovani; Andrea Panzacchi; Alessandra Bertoldo; Barbara Borroni; Stefano Francesco Cappa; Assunta Carpinelli; Ioana Florea; Valentina Garibotto; Karl Herholz; Juha O Rinne; Marco Tettamanti; Jere R Virta; Daniela Perani
[11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis.
Journal of Alzheimer's disease : JAD 2012;31(2):387-99.
2011: Venla S Laitala; Ismo Räihä; Juha O Rinne; Kaare Christensen; Jacob v B Hjelmborg; Jaakko Kaprio; Markku Koskenvuo; Karri Silventoinen
Shorter adult stature increases the impact of risk factors for cognitive impairment: a comparison of two Nordic twin cohorts.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2011;14(6):544-52.
2011: Myoung Soo Kwon; Matti Laine; Harri Lindholm; Juha O Rinne; Mika Teräs; Tommi Toivonen; Victor A Vorobyev; Tommi Alanko; Jarkko Johansson; Sami Kännälä; Heikki Hämäläinen
GSM mobile phone radiation suppresses brain glucose metabolism.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2011;31(12):2293-301.
2011: Lars Bäckman; Erika Dahlin; Jarkko Johansson; Matti Laine; Anna S Neely; Lars Nyberg; Anna Soveri; Jere Virta; Micael Andersson; Juha O Rinne
Effects of working-memory training on striatal dopamine release.
Science (New York, N.Y.) 2011;333(6043):718.
2011: Jere R Virta; Sari Laatu; Vesa Oikonen; Riitta Parkkola; Juha O Rinne; Juhani Ruutiainen
Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(8):931-8.
2011: A Östberg; J Virta; Juha O Rinne; Vesa Oikonen; P Luoto; Kjell Någren; E Arponen; Olli Tenovuo
Cholinergic dysfunction after traumatic brain injury: preliminary findings from a PET study.
Neurology 2011;76(12):1046-50.
2011: J Koivunen; N Scheinin; J R Virta; Sargo Aalto; T Vahlberg; Kjell Någren; Semi Helin; Riitta Parkkola; Matti Viitanen; Juha O Rinne
Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.
Neurology 2011;76(12):1085-90.
2011: Kati Alakurtti; Sargo Aalto; Jarkko J Johansson; Kjell Någren; Terhi Tuokkola; Vesa Oikonen; Matti Laine; Juha O Rinne
Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2011;31(1):155-65.
2010: Pekka Jokinen; Noora Scheinin; Sargo Aalto; Kjell Någren; Nina Savisto; Riitta Parkkola; Johanna Rokka; Merja Haaparanta; Matias Röyttä; Juha O Rinne
[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
Parkinsonism & related disorders 2010;16(10):666-70.
2010: Eero Rissanen; Teemu Paavilainen; Jere Virta; Reijo J Marttila; Juha O Rinne; Laura Airas
Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
Neurotoxicology 2010;31(4):403-7.
2010: Kjell Någren; Christer Halldin; Juha O Rinne
Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease.
European journal of nuclear medicine and molecular imaging 2010;37(8):1575-93.
2010: Lauri T Haltia; Eriika Savontaus; Tero Vahlberg; Juha O Rinne; Valtteri Kaasinen
Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects.
Scandinavian journal of clinical and laboratory investigation 2010;70(4):275-80.
2010: Timo Suotunen; Jussi Hirvonen; Pirjo Immonen-Räihä; Sargo Aalto; Irina Lisinen; Eveliina Arponen; Mika Teräs; Kari Koski; Raimo Sulkava; Marko Seppänen; Juha O Rinne
Visual assessment of [(11)C]PIB PET in patients with cognitive impairment.
European journal of nuclear medicine and molecular imaging 2010;37(6):1141-7.
2010: Juha O Rinne; David J Brooks; Martin N Rossor; Nick C Fox; Roger Bullock; William E Klunk; Chester A Mathis; Kaj Blennow; Jerome Barakos; Aren A Okello; Sofia Rodriguez Martinez de Liano; Enchi Liu; Martin Koller; Keith M Gregg; Dale Schenk; Ronald Black; Michael Grundman
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.
Lancet neurology 2010;9(4):363-72.
2010: Mika M Hirvonen; Kjell Någren; Juha O Rinne; Ullamari Pesonen; Tero Vahlberg; Nora Hagelberg; Jarmo Hietala
COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(2):192-7.
2010: Lisa Mosconi; Juha O Rinne; Wai H Tsui; Valentina Berti; Yi Li; Huiyu Wang; John Murray; Noora Scheinin; Kjell Någren; Schantel Williams; Lidia Glodzik; Susan De Santi; Shankar Vallabhajosula; Mony J de Leon
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(13):5949-54.
2010: Petra Grönholm-Nyman; Juha O Rinne; Matti Laine
Learning and forgetting new names and objects in MCI and AD.
Neuropsychologia 2010;48(4):1079-88.
2010: Jussi Hirvonen; Anne Roivainen; Jere Virta; Semi Helin; Kjell Någren; Juha O Rinne
Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation.
European journal of nuclear medicine and molecular imaging 2010;37(3):606-12.
2010: agneta nordberg; Juha O Rinne; Ahmadul Kadir; Bengt Långström
The use of PET in Alzheimer disease.
Nature reviews. Neurology 2010;6(2):78-87.
2010: Jyri J Virtaa; Tarja Järvenpää; Kauko Heikkilä; Markus Perola; Markku Koskenvuo; Ismo Räihä; Juha O Rinne; Jaakko Kaprio
Midlife alcohol consumption and later risk of cognitive impairment: a twin follow-up study.
Journal of Alzheimer's disease : JAD 2010;22(3):939-48.
2010: Chul Hyoung Lyoo; Yong Jeong; Young Hoon Ryu; Juha O Rinne; Myung Sik Lee
Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
European neurology 2010;64(2):65-73.
2010: Juha O Rinne; Kjell Någren
Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2010;19(1):291-300.
2009: Markus M Lindroos; Ronald Borra; Riitta Parkkola; Sami M Virtanen; Virva Lepomäki; Marco Bucci; Jere R Virta; Juha O Rinne; Pirjo Nuutila; Kari Majamaa
Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation.
Brain : a journal of neurology 2009;132(Pt 12):3274-84.
2009: Mika M Hirvonen; Aki Laakso; Kjell Någren; Juha O Rinne; Tiina Pohjalainen; Jarmo Hietala
C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.
Synapse (New York, N.Y.) 2009;63(10):907-12.
2009: Sargo Aalto; Noora M Scheinin; Nina M Kemppainen; Kjell Någren; Marita Kailajärvi; Mika Leinonen; Mika Scheinin; Juha O Rinne
Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
European journal of nuclear medicine and molecular imaging 2009;36(10):1651-60.
2009: Venla S Laitala; Jaakko Kaprio; Markku Koskenvuo; Ismo Räihä; Juha O Rinne; Karri Silventoinen
Coffee drinking in middle age is not associated with cognitive performance in old age.
The American journal of clinical nutrition 2009;90(3):640-6.
2009: Pekka Jokinen; Hans Helenius; Elina Rauhala; Anna Brück; Olli Eskola; Juha O Rinne
Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(6):893-9.
2009: Anna Brück; Sargo Aalto; Elina Rauhala; Jörgen Bergman; Reijo J Marttila; Juha O Rinne
A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen.
Movement disorders : official journal of the Movement Disorder Society 2009;24(7):1009-15.
2009: J Hirvonen; Marita E H Kailajärvi; T Haltia; S Koskimies; Kjell Någren; P Virsu; Vesa Oikonen; Hannu Sipilä; P Ruokoniemi; K Virtanen; Mika Scheinin; Juha O Rinne
Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
Clinical pharmacology and therapeutics 2009;85(5):506-12.
2009: Anne Roivainen; Kjell Någren; Jussi Hirvonen; Vesa Oikonen; Pauliina Virsu; Tuula Tolvanen; Juha O Rinne
Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography.
European journal of nuclear medicine and molecular imaging 2009;36(4):671-82.
2009: Sargo Aalto; Jussi Hirvonen; Valtteri Kaasinen; Nora Hagelberg; Jaana Kajander; Kjell Någren; Timo Seppälä; Juha O Rinne; Harry Scheinin; Jarmo Hietala
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
European journal of nuclear medicine and molecular imaging 2009;36(3):475-83.
2009: J J Virta; Sargo Aalto; Tarja Järvenpää; Mira Karrasch; Jaakko Kaprio; Markku Koskenvuo; Ismo Räihä; T Viljanen; Juha O Rinne
Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease.
Journal of neurology, neurosurgery, and psychiatry 2009;80(3):259-66.
2009: Matti Laine; Terhi Tuokkola; Jaana Hiltunen; Victor A Vorobyev; Irina Bliss; Alan Baddeley; Juha O Rinne
Central executive function in mild cognitive impairment: a PET activation study.
Scandinavian journal of psychology 2009;50(1):33-40.
2009: Pekka Jokinen; Anna Brück; Sargo Aalto; Sarita Forsback; Riitta Parkkola; Juha O Rinne
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.
Parkinsonism & related disorders 2009;15(2):88-93.
2008: Olli Tenovuo; Nina Kemppainen; Sargo Aalto; Kjell Någren; Juha O Rinne
Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation.
Journal of Alzheimer's disease : JAD 2008;15(3):351-5.
2008: Juha O Rinne; Shuang Yong Ma; Myung Sik Lee; Yrjö Collan; Matias Röyttä
Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients.
Parkinsonism & related disorders 2008;14(7):553-7.
2008: Ville Leinonen; Irina Alafuzoff; Sargo Aalto; Timo Suotunen; S Savolainen; Kjell Någren; Tero Tapiola; Tuula Pirttilä; Jaakko Rinne; Juha E Jääskeläinen; Hilkka Soininen; Juha O Rinne
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
Archives of neurology 2008;65(10):1304-9.
2008: Lauri T Haltia; Juha O Rinne; Semi Helin; Riitta Parkkola; Kjell Någren; Valtteri Kaasinen
Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function.
Synapse (New York, N.Y.) 2008;62(9):682-8.
2008: Jussi Koivunen; A Verkkoniemi; Sargo Aalto; A Paetau; J-P Ahonen; Matti Viitanen; Kjell Någren; J Rokka; Merja Haaparanta; Hannu Kalimo; Juha O Rinne
PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.
Brain : a journal of neurology 2008;131(Pt 7):1845-53.
2008: Anne M Remes; Lauri Laru; Hannu Tuominen; Sargo Aalto; Nina Kemppainen; H Mononen; Kjell Någren; Riitta Parkkola; Juha O Rinne
Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.
Archives of neurology 2008;65(4):540-4.
2008: Jere R Virta; Tuula Tolvanen; Kjell Någren; Anna Brück; Anne Roivainen; Juha O Rinne
1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(3):347-53.
2008: Chul Hyoung Lyoo; Y Jeong; Y H Ryu; S Y Lee; T J Song; J H Lee; Juha O Rinne; Myung Sik Lee
Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
Brain : a journal of neurology 2008;131(Pt 2):438-46.
2008: Jussi Koivunen; T Pirttilä; Nina Kemppainen; S Aalto; S-K Herukka; A M Jauhianen; T Hänninen; M Hallikainen; Kjell Någren; Juha O Rinne; Hilkka Soininen
PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment.
Dementia and geriatric cognitive disorders 2008;26(4):378-83.
2008: Jyri J Virta; Mira Karrasch; Jaakko Kaprio; Markku Koskenvuo; Ismo Räihä; Tapio Viljanen; Juha O Rinne
Cerebral glucose metabolism in dizygotic twin pairs discordant for Alzheimer's disease.
Dementia and geriatric cognitive disorders 2008;25(1):9-16.
2008: Nina Kemppainen; Sargo Aalto; Mira Karrasch; Kjell Någren; Nina Savisto; Vesa Oikonen; Matti Viitanen; Riitta Parkkola; Juha O Rinne
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.
Annals of neurology 2008;63(1):112-8.
2007: Chul Hyoung Lyoo; Sargo Aalto; Juha O Rinne; Ki Ook Lee; Seung Hun Oh; Jin Woo Chang; Myung Sik Lee
Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait.
Movement disorders : official journal of the Movement Disorder Society 2007;22(15):2176-82.
2007: Lauri T Haltia; Juha O Rinne; Harri Merisaari; Ralph P Maguire; Eriika Savontaus; Semi Helin; Kjell Någren; Valtteri Kaasinen
Effects of intravenous glucose on dopaminergic function in the human brain in vivo.
Synapse (New York, N.Y.) 2007;61(9):748-56.
2007: Lauri T Haltia; Antti Viljanen; Riitta Parkkola; Nina Kemppainen; Juha O Rinne; Pirjo Nuutila; Valtteri Kaasinen
Brain white matter expansion in human obesity and the recovering effect of dieting.
The Journal of clinical endocrinology and metabolism 2007;92(8):3278-84.
2007: Petra Grönholm; Juha O Rinne; Victor A Vorobyev; Matti Laine
Neural correlates of naming newly learned objects in MCI.
Neuropsychologia 2007;45(10):2355-68.
2007: Nina Kemppainen; Sargo Aalto; Ian wilson; Kjell Någren; Semi Helin; Anna Brück; Vesa Oikonen; Marita E H Kailajärvi; Mika Scheinin; Matti Viitanen; Riitta Parkkola; Juha O Rinne
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.
Neurology 2007;68(19):1603-6.
2007: Christopher J A Moulin; Matti Laine; Juha O Rinne; Valtteri Kaasinen; Hannu Sipilä; Jaana Hiltunen; Aki Kangasmäki
Brain function during multi-trial learning in mild cognitive impairment: a PET activation study.
Brain research 2007;1136(1):132-41.
2007: Noora M Scheinin; Tuula Tolvanen; Ian wilson; Eveliina M Arponen; Kjell Någren; Juha O Rinne
Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(1):128-33.
2006: Nina Kemppainen; Sargo Aalto; Ian wilson; Kjell Någren; Semi Helin; Anna Brück; Vesa Oikonen; Marita E H Kailajärvi; Mika Scheinin; Matti Viitanen; Riitta Parkkola; Juha O Rinne
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.
Neurology 2006;67(9):1575-80.
2006: Anna Brück; Sargo Aalto; Elina Nurmi; Tero Vahlberg; Jörgen Bergman; Juha O Rinne
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(7):958-63.
2006: Sargo Aalto; Christian Haarala; Anna Brück; Hannu Sipilä; Heikki Hämäläinen; Juha O Rinne
Mobile phone affects cerebral blood flow in humans.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2006;26(7):885-90.
2006: Joumana Hudry; Juha O Rinne; Tapani Keränen; Laurent Eckert; John M Cochran
Cost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland.
The Annals of pharmacotherapy 2006;40(4):651-7.
2006: Mira Karrasch; Matti Laine; Juha O Rinne; Pekka Rapinoja; Eija Sinervä; Christina M Krause
Brain oscillatory responses to an auditory-verbal working memory task in mild cognitive impairment and Alzheimer's disease.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2006;59(2):168-78.
2006: Marika Saarela; Terho Lehtimaki; Juha O Rinne; Heini Huhtala; Riikka Rontu; Antti Hervonen; Matias Roytta; Jukka-Pekka Ahonen; Kari M Mattila
No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2006;44(1):12-6.
2005: Tarja Järvenpää; Juha O Rinne; Markku Koskenvuo; Ismo Räihä; Jaakko Kaprio
Binge drinking in midlife and dementia risk.
Epidemiology (Cambridge, Mass.) 2005;16(6):766-71.
2005: Petra Grönholm; Juha O Rinne; Victor A Vorobyev; Matti Laine
Naming of newly learned objects: a PET activation study.
Brain research. Cognitive brain research 2005;25(1):359-71.
2005: Anna Brück; Sargo Aalto; Elina Nurmi; Jörgen Bergman; Juha O Rinne
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
Neurobiology of aging 2005;26(6):891-8.
2005: Sargo Aalto; Anna Brück; Matti Laine; Kjell Någren; Juha O Rinne
Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(10):2471-7.
2005: Valtteri Kaasinen; R P Maguire; Timo Kurki; Anna Brück; Juha O Rinne
Mapping brain structure and personality in late adulthood.
NeuroImage 2005;24(2):315-22.
2004: M Hirvonen; Aki Laakso; Kjell Någren; Juha O Rinne; Tiina Pohjalainen; Jarmo Hietala
C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.
Molecular psychiatry 2004;9(12):1060-1.
2004: Valtteri Kaasinen; Sargo Aalto; Kjell Någren; Juha O Rinne
Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2004;19(11):1348-51.
2004: Anna Brück; Timo Kurki; Valtteri Kaasinen; Tero Vahlberg; Juha O Rinne
Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment.
Journal of neurology, neurosurgery, and psychiatry 2004;75(10):1467-9.
2004: Marika Saarela; Terho Lehtimäki; Juha O Rinne; Antti Hervonen; Marja Jylhä; Matias Röyttä; Jukka-Pekka Ahonen; Kari M Mattila
Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
Neuroscience letters 2004;367(3):336-9.
2004: Petri Luoma; Atle Melberg; Juha O Rinne; Jyrki A Kaukonen; Nina N Nupponen; Richard M Chalmers; Anders Oldfors; Ilkka Rautakorpi; Leena Peltonen; Kari Majamaa; Hannu Somer; Anu Suomalainen
Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.
Lancet 2004;364(9437):875-82.
2004: Sari Laatu; Antti Revonsuo; Laura Pihko; Raija Portin; Juha O Rinne
Visual object recognition deficits in early Parkinson's disease.
Parkinsonism & related disorders 2004;10(4):227-33.
2004: Susanna Tuominen; Qing Miao; Timo Kurki; Seppo Tuisku; Minna Pöyhönen; Hannu Kalimo; Matti Viitanen; Hannu Sipilä; Jörgen Bergman; Juha O Rinne
Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients.
Stroke; a journal of cerebral circulation 2004;35(5):1063-7.
2004: Valtteri Kaasinen; Sargo Aalto; Kjell Någren; Juha O Rinne
Expectation of caffeine induces dopaminergic responses in humans.
The European journal of neuroscience 2004;19(8):2352-6.
2004: Auli Verkkoniemi; Raija Ylikoski; Juha O Rinne; Mirja Somer; Aki Hietaharju; Timo Erkinjuntti; Matti Viitanen; Hannu Kalimo; Matti Haltia
Neuropsychological functions in variant Alzheimer's disease with spastic paraparesis.
Journal of the neurological sciences 2004;218(1-2):29-37.
2004: Valtteri Kaasinen; Sargo Aalto; Kjell Någren; Juha O Rinne
Dopaminergic effects of caffeine in the human striatum and thalamus.
Neuroreport 2004;15(2):281-5.
2004: Juha O Rinne; M Iivanainen; Liisa Metsähonkala; Leena Vainionpää; L Pääkkönen; K Någren; H Helenius
Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(1):59-67.
2004: Tarja Järvenpää; M P Laakso; R Rossi; Markku Koskenvuo; Jaakko Kaprio; Ismo Räihä; Timo Kurki; Matti Laine; Giovanni B Frisoni; Juha O Rinne
Hippocampal MRI volumetry in cognitively discordant monozygotic twin pairs.
Journal of neurology, neurosurgery, and psychiatry 2004;75(1):116-20.
2004: Juha O Rinne; Christer Hublin; Kjell Någren; Hans Helenius; Markku Partinen
Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with [11C]-CFT.
Acta neurologica Scandinavica 2004;109(1):52-5.
2003: Juha O Rinne; Matti Laine; Jaana Hiltunen; Timo Erkinjuntti
Semantic decision making in early probable AD: a PET activation study.
Brain research. Cognitive brain research 2003;18(1):89-96.
2003: Christian Haarala; Sargo Aalto; Hubertus Hautzel; Laura Julkunen; Juha O Rinne; Matti Laine; Bernd Krause; Heikki Hämäläinen
Effects of a 902 MHz mobile phone on cerebral blood flow in humans: a PET study.
Neuroreport 2003;14(16):2019-23.
2003: Nora Hagelberg; Heli Forssell; Sargo Aalto; Juha O Rinne; Harry Scheinin; Tero Taiminen; Kjell Någren; Olli Eskola; Satu Jääskeläinen
Altered dopamine D2 receptor binding in atypical facial pain.
Pain 2003;106(1-2):43-8.
2003: Tarja Järvenpää; Ismo Räihä; Jaakko Kaprio; Markku Koskenvuo; Matti Laine; Timo Kurki; Tapio Viljanen; Juha O Rinne
A 90-year-old monozygotic female twin pair discordant for Alzheimer's disease.
Neurobiology of aging 2003;24(7):941-5.
2003: Juha O Rinne
Endogenous dopamine release in Parkinson's disease.
Lancet neurology 2003;2(8):460-1.
2003: Sari Laatu; Antti Revonsuo; H Jäykkä; Raija Portin; Juha O Rinne
Visual object recognition in early Alzheimer's disease: deficits in semantic processing.
Acta neurologica Scandinavica 2003;108(2):82-9.
2003: Nina Kemppainen; Matti Laine; M P Laakso; Valtteri Kaasinen; Kjell Någren; Tero Vahlberg; Timo Kurki; Juha O Rinne
Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease.
The European journal of neuroscience 2003;18(1):149-54.
2003: Elina Nurmi; Jörgen Bergman; Olli Eskola; Olof Solin; Tero Vahlberg; Pirkko Sonninen; Juha O Rinne
Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
Synapse (New York, N.Y.) 2003;48(3):109-15.
2003: Kari M Mattila; Mikko Hiltunen; Juha O Rinne; Arto Mannermaa; Matias Röyttä; Irina Alafuzoff; Pekka Laippala; Hilkka Soininen; Terho Lehtimäki
Absence of association between an intercellular adhesion molecule 1 gene E469K polymorphism and Alzheimer's disease in Finnish patients.
Neuroscience letters 2003;337(1):61-3.
2003: Kati Renvall; Matti Laine; Jaana Hiltunen; Juha O Rinne; Valtteri Kaasinen; Hannu Sipilä; Katri Cornelissen; Nadine Martin
Naming multiple objects: neural correlates as measured by positron emission tomography.
Applied neuropsychology 2003;10(4):224-33.
2003: Tarja Järvenpää; Ismo Räihä; Jaakko Kaprio; Markku Koskenvuo; Matti Laine; Timo Kurki; Tero Vahlberg; Tapio Viljanen; Kirsi Ahonen; Juha O Rinne
Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease.
Dementia and geriatric cognitive disorders 2003;16(4):245-52.
2003: Juha O Rinne; Ismo Ulmanen; Myung-Sik Lee
Catechol-O-methyl transferase (COMT) inhibitors in patients with Parkinson's disease: is COMT genotype a useful indicator of clinical efficacy?
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 2003;3(1):11-5.
2003: Nora Hagelberg; Heli Forssell; Juha O Rinne; Harry Scheinin; Tero Taiminen; Sargo Aalto; Sinikka Luutonen; Kjell Någren; Satu Jääskeläinen
Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
Pain 2003;101(1-2):149-54.
2003: Juha O Rinne; Valtteri Kaasinen; Tarja Järvenpää; Kjell Någren; Anne Roivainen; Meixiang Yu; Vesa Oikonen; Timo Kurki
Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2003;74(1):113-5.
2002: Valtteri Kaasinen; Kjell Någren; Tarja Järvenpää; Anne Roivainen; Meixiang Yu; Vesa Oikonen; Timo Kurki; Juha O Rinne
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
Journal of clinical psychopharmacology 2002;22(6):615-20.
2002: Zhi-Zhong Guan; agneta nordberg; Malahat Mousavi; Juha O Rinne; Ewa Hellström-Lindahl
Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease.
Brain research 2002;956(2):358-66.
2002: Valtteri Kaasinen; Juha O Rinne
Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease.
Neuroscience and biobehavioral reviews 2002;26(7):785-93.
2002: Valtteri Kaasinen; Elina Nurmi; Jörgen Bergman; Olof Solin; Timo Kurki; Juha O Rinne
Personality traits and striatal 6-[18F]fluoro-L-dopa uptake in healthy elderly subjects.
Neuroscience letters 2002;332(1):61-4.
2002: Kari M Mattila; Juha O Rinne; Matias Röyttä; Pekka Laippala; Terho Lehtimäki
Lack of association between an estrogen receptor 1 gene polymorphism and Parkinson's disease with dementia.
Acta neurologica Scandinavica 2002;106(3):128-30.
2002: Juha O Rinne; HM Ruottinen; Kjell Någren; Laura E Aberg; Pirkko Santavuori
Positron emission tomography shows reduced striatal dopamine D1 but not D2 receptors in juvenile neuronal ceroid lipofuscinosis.
Neuropediatrics 2002;33(3):138-41.
2002: Valtteri Kaasinen; Nina Kemppainen; Kjell Någren; Hans Helenius; Timo Kurki; Juha O Rinne
Age-related loss of extrastriatal dopamine D(2) -like receptors in women.
Journal of neurochemistry 2002;81(5):1005-10.
2002: Juha O Rinne; Oleg V Anichtchik; KS Eriksson; Jan Kaslin; Leena Tuomisto; Hannu Kalimo; Matias Röyttä; Pertti Panula
Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy.
Journal of neurochemistry 2002;81(5):954-60.
2002: Juha O Rinne; M Laine; Valtteri Kaasinen; MK Norvasuo-Heilä; Kjell Någren; Hans Helenius
Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia.
Neurology 2002;58(10):1489-93.
2002: Niina Snäll; Marja-Liisa Savontaus; Saara Kares; Myung Sik Lee; Eun Kyung Cho; Juha O Rinne; Kirsi Huoponen
A rare mitochondrial DNA haplotype observed in Koreans.
Human biology 2002;74(2):253-62.
2002: Myung Sik Lee; Hyun-Sook Kim; E K Cho; J H Lim; Juha O Rinne
COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease.
Neurology 2002;58(4):564-7.
2002: Matti Laine; Juha O Rinne; Jaana Hiltunen; Valtteri Kaasinen; Hannu Sipilä
Different brain activation patterns during production of animals versus artefacts: a PET activation study on category-specific processing.
Brain research. Cognitive brain research 2002;13(1):95-9.
2002: Tarja Järvenpää; Juha O Rinne; Ismo Räihä; Markku Koskenvuo; Minna Löppönen; Susanna Hinkka; Jaakko Kaprio
Characteristics of two telephone screens for cognitive impairment.
Dementia and geriatric cognitive disorders 2002;13(3):149-55.
2002: Nina Kemppainen; Matias Röyttä; Y Collan; S Y Ma; Susanna Hinkka; Juha O Rinne
Unbiased morphological measurements show no neuronal loss in the substantia nigra in Alzheimer's disease.
Acta neuropathologica 2002;103(1):43-7.
2001: Valtteri Kaasinen; Elina Nurmi; Jörgen Bergman; Olli Eskola; Olof Solin; Pirkko Sonninen; Juha O Rinne
Personality traits and brain dopaminergic function in Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(23):13272-7.
2001: Anna Brück; Raija Portin; Arja B Lindell; A Laihinen; Jörgen Bergman; Merja Haaparanta; Olof Solin; Juha O Rinne
Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus.
Neuroscience letters 2001;311(2):81-4.
2001: PM Mattila; Matias Röyttä; P Lönnberg; Päivi Marjamäki; Hans Helenius; Juha O Rinne
Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
Acta neuropathologica 2001;102(2):160-6.
2001: Susanna Tuominen; Vesa Juvonen; Kaarina Amberla; T Jolma; Juha O Rinne; Seppo Tuisku; Timo Kurki; Reijo J Marttila; Minna Pöyhönen; Marja-Liisa Savontaus; Matti Viitanen; Hannu Kalimo
Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation.
Stroke; a journal of cerebral circulation 2001;32(8):1767-74.
2001: Elina Nurmi; HM Ruottinen; Jörgen Bergman; Merja Haaparanta; Olof Solin; Pirkko Sonninen; Juha O Rinne
Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):608-15.
2001: Valtteri Kaasinen; Elina Nurmi; Anna Brück; Olli Eskola; Jörgen Bergman; Olof Solin; Juha O Rinne
Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex.
Brain : a journal of neurology 2001;124(Pt 6):1125-30.
2001: Laura E Aberg; Juha O Rinne; Iiro Rajantie; Pirkko Santavuori
A favorable response to antiparkinsonian treatment in juvenile neuronal ceroid lipofuscinosis.
Neurology 2001;56(9):1236-9.
2001: Satu Jääskeläinen; Juha O Rinne; Heli Forssell; Olli Tenovuo; Valtteri Kaasinen; Pirkko Sonninen; J Bergman
Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study.
Pain 2001;90(3):257-60.
2001: Valtteri Kaasinen; Kjell Någren; Jarmo Hietala; Lars Farde; Juha O Rinne
Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain.
The American journal of psychiatry 2001;158(2):308-11.
2001: Nina Kemppainen; Päivi Marjamäki; Matias Röyttä; Juha O Rinne
Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(7):827-36.
2000: Juha O Rinne; J Tommola; Matti Laine; Bernd J Krause; D Schmidt; Valtteri Kaasinen; Mika Teräs; Hannu Sipilä; M Sunnari
The translating brain: cerebral activation patterns during simultaneous interpreting.
Neuroscience letters 2000;294(2):85-8.
2000: Elina Nurmi; Jörgen Bergman; Olli Eskola; Olof Solin; Susanna Hinkka; Pirkko Sonninen; Juha O Rinne
Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2000;20(11):1604-9.
2000: PM Mattila; Juha O Rinne; Hans Helenius; dennis dickson; Matias Röyttä
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
Acta neuropathologica 2000;100(3):285-90.
2000: Nina Kemppainen; HM Ruottinen; K Nâgren; Juha O Rinne
PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD.
Neurology 2000;55(2):205-9.
2000: Salla Lamusuo; Asla Pitkänen; Leena Jutila; Aarne Ylinen; Kaarina Partanen; Reetta Kälviäinen; HM Ruottinen; Vesa Oikonen; Kjell Någren; Pertti Lehikoinen; Matti Vapalahti; Pauli Vainio; Juha O Rinne
[11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology.
Neurology 2000;54(12):2252-60.
2000: Elina Nurmi; HM Ruottinen; Valtteri Kaasinen; Jörgen Bergman; Merja Haaparanta; Olof Solin; Juha O Rinne
Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
Annals of neurology 2000;47(6):804-8.
2000: Valtteri Kaasinen; Kjell Någren; Jarmo Hietala; Vesa Oikonen; Harry Vilkman; Lars Farde; Christer Halldin; Juha O Rinne
Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.
Neurology 2000;54(7):1482-7.
2000: A Laihinen; HM Ruottinen; Juha O Rinne; Merja Haaparanta; Jörgen Bergman; Olof Solin; M Koskenvuo; Reijo J Marttila; UK Rinne
Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET.
Journal of neurology 2000;247 Suppl 2():II110-3.
2000: Juha O Rinne; Raija Portin; HM Ruottinen; Elina Nurmi; Jörgen Bergman; Merja Haaparanta; Olof Solin
Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Archives of neurology 2000;57(4):470-5.
2000: Auli Verkkoniemi; Mirja Somer; Juha O Rinne; Liisa Myllykangas; Richard Crook; John Hardy; Matti Viitanen; Hannu Kalimo; Matti Haltia
Variant Alzheimer's disease with spastic paraparesis: clinical characterization.
Neurology 2000;54(5):1103-9.
2000: Laura E Aberg; K Liewendahl; Paivi Nikkinen; Taina Autti; Juha O Rinne; Pirkko Santavuori
Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms.
Neurology 2000;54(5):1069-74.
2000: HM Ruottinen; Markku Partinen; Christer Hublin; Jörgen Bergman; Merja Haaparanta; Olof Solin; Juha O Rinne
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome.
Neurology 2000;54(2):502-4.
2000: Valtteri Kaasinen; HM Ruottinen; Kjell Någren; Pertti Lehikoinen; Vesa Oikonen; Juha O Rinne
Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(1):65-70.
1999: Juha O Rinne; HM Ruottinen; Jörgen Bergman; Merja Haaparanta; Pirkko Sonninen; Olof Solin
Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1999;67(6):737-41.
1999: S Y Ma; M Röytt; Y Collan; Juha O Rinne
Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing.
Neuropathology and applied neurobiology 1999;25(5):394-9.
1999: Matti Laine; Juha O Rinne; Bernd J Krause; Mika Teräs; Hannu Sipilä
Left hemisphere activation during processing of morphologically complex word forms in adults.
Neuroscience letters 1999;271(2):85-8.
1999: PM Mattila; Juha O Rinne; Hans Helenius; Matias Röyttä
Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology.
Acta neuropathologica 1999;98(2):157-64.
1999: Salla Lamusuo; Nina Forss; HM Ruottinen; Jörgen Bergman; Jyrki Makela; Esa Mervaala; Olof Solin; J K Rinne; Ulla Ruotsalainen; Aarne Ylinen; Matti Vapalahti; R Hari; Juha O Rinne
[18F]FDG-PET and whole-scalp MEG localization of epileptogenic cortex.
Epilepsia 1999;40(7):921-30.
1999: Juha O Rinne; Jörgen Bergman; HM Ruottinen; Merja Haaparanta; E Eronen; Vesa Oikonen; Pirkko Sonninen; Olof Solin
Striatal uptake of a novel PET ligand, [18F]beta-CFT, is reduced in early Parkinson's disease.
Synapse (New York, N.Y.) 1999;31(2):119-24.
1998: PM Mattila; T Koskela; Matias Röyttä; Terho Lehtimäki; T A Pirttilä; E Ilveskoski; Pekka J Karhunen; Juha O Rinne
Apolipoprotein E epsilon4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology.
Acta neuropathologica 1998;96(4):417-20.
1998: PM Mattila; Matias Röyttä; H Torikka; dennis dickson; Juha O Rinne
Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease.
Acta neuropathologica 1998;95(6):576-82.
1998: Tiina Pohjalainen; Juha O Rinne; Kjell Någren; Erkka Syvälahti; Jarmo Hietala
Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo.
The American journal of psychiatry 1998;155(6):768-73.
1998: Tiina Pohjalainen; Juha O Rinne; Kjell Någren; Pertti Lehikoinen; K Anttila; Erkka Syvälahti; Jarmo Hietala
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.
Molecular psychiatry 1998;3(3):256-60.
1998: Juha O Rinne; N Sahlberg; HM Ruottinen; Kjell Någren; Pertti Lehikoinen
Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography.
Neurology 1998;50(1):152-6.
1997: Salla Lamusuo; HM Ruottinen; J Knuuti; R Härkönen; Ulla Ruotsalainen; Jörgen Bergman; Merja Haaparanta; Olof Solin; Esa Mervaala; U Nousiainen; Satu Jääskeläinen; Aarne Ylinen; Reetta Kälviäinen; J K Rinne; Matti Vapalahti; Juha O Rinne
Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex.
Journal of neurology, neurosurgery, and psychiatry 1997;63(6):743-8.
1997: HM Ruottinen; Juha O Rinne; Vesa Oikonen; JR Bergman; Merja Haaparanta; Olof Solin; Ulla Ruotsalainen; UK Rinne
Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Synapse (New York, N.Y.) 1997;27(4):336-46.
1997: S Y Ma; Matias Röyttä; Juha O Rinne; Y Collan; UK Rinne
Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts.
Journal of the neurological sciences 1997;151(1):83-7.
1997: HM Ruottinen; Juha O Rinne; Merja Haaparanta; Olof Solin; Jörgen Bergman; Vesa Oikonen; I Järvelä; Pirkko Santavuori
[18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis.
Journal of neurology, neurosurgery, and psychiatry 1997;62(6):622-5.
1997: Juha O Rinne; J T Kuikka; K A Bergström; J Hiltunen; H Kilpelainen
Striatal Dopamine transporter in Parkinson's disease: A Study With a New Radioligand, [(123)I]B-CIT-FP.
Parkinsonism & related disorders 1997;3(2):77-81.
1997: M Laine; E Vuorinen; Juha O Rinne
Picture naming deficits in vascular dementia and Alzheimer's disease.
Journal of clinical and experimental neuropsychology 1997;19(1):126-40.
1996: Juha O Rinne; C Hublin; M Partinen; HM Ruottinen; Kjell Någren; Pertti Lehikoinen; Ulla Ruotsalainen; A Laihinen
Striatal dopamine D1 receptors in narcolepsy: a PET study with [11C]NNC 756.
Journal of sleep research 1996;5(4):262-4.
1996: S Y Ma; Juha O Rinne; Y Collan; M Röyttä; UK Rinne
A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease.
Journal of the neurological sciences 1996;140(1-2):40-5.
1996: Mika Koivisto; Raija Portin; Juha O Rinne
Perceptual priming in Alzheimer's and Parkinson's diseases.
Neuropsychologia 1996;34(5):449-57.
1995: Juha O Rinne; A Laihinen; Kjell Någren; HM Ruottinen; Ulla Ruotsalainen; UK Rinne
PET examination of the monoamine transporter with [11C]beta-CIT and [11C]beta-CFT in early Parkinson's disease.
Synapse (New York, N.Y.) 1995;21(2):97-103.
1995: Juha O Rinne; A Laihinen; HM Ruottinen; Ulla Ruotsalainen; Kjell Någren; Pertti Lehikoinen; Vesa Oikonen; UK Rinne
Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
Journal of the neurological sciences 1995;132(2):156-61.
1995: Juha O Rinne; C Hublin; M Partinen; HM Ruottinen; Ulla Ruotsalainen; Kjell Någren; Pertti Lehikoinen; A Laihinen
Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
Neurology 1995;45(9):1735-8.
1995: S Y Ma; M Röyttä; Juha O Rinne; Y Collan; UK Rinne
Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease.
Neuropathology and applied neurobiology 1995;21(4):341-3.
1995: A O Laihinen; Juha O Rinne; Kjell Någren; Pertti Lehikoinen; Vesa Oikonen; Ulla Ruotsalainen; HM Ruottinen; UK Rinne
PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1263-7.
1995: S Y Ma; Y Collan; M Röyttä; Juha O Rinne; UK Rinne
Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls.
Neuropathology and applied neurobiology 1995;21(1):10-7.
1995: HM Ruottinen; Juha O Rinne; Ulla Ruotsalainen; J R Bergman; Vesa Oikonen; Merja Haaparanta; Olof Solin; A O Laihinen; UK Rinne
Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1995;10(2-3):91-106.
1994: A O Laihinen; Juha O Rinne; HM Ruottinen; Kjell Någren; Pertti Lehikoinen; Vesa Oikonen; Ulla Ruotsalainen; UK Rinne
PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(12):1916-20.
1994: R Salonen; Juha O Rinne; P Halonen; A Puusa; Reijo J Marttila; Matti K Viljanen
Lyme borreliosis associated with complete flaccid paraplegia.
The Journal of infection 1994;28(2):181-4.
1993: Juha O Rinne; P Lönnberg; P Marjamäki; P Mölsä; E Säkö; L Paljärvi
Brain methionine- and leucine-enkephalin receptors in patients with dementia.
Neuroscience letters 1993;161(1):77-80.
1993: Juha O Rinne; P Lönnberg; P Marjamäki
Human brain methionine- and leucine-enkephalins and their receptors during ageing.
Brain research 1993;624(1-2):131-6.
1993: Juha O Rinne; A Laihinen; UK Rinne; Kjell Någren; Jörgen Bergman; Ulla Ruotsalainen
PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):134-8.
1993: Juha O Rinne; Jarmo Hietala; Ulla Ruotsalainen; E Säkö; A Laihinen; Kjell Någren; Pertti Lehikoinen; Vesa Oikonen; Erkka Syvälahti
Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1993;13(2):310-4.
1993: Antti Revonsuo; Raija Portin; L Koivikko; Juha O Rinne; UK Rinne
Slowing of information processing in Parkinson's disease.
Brain and cognition 1993;21(1):87-110.
1993: Juha O Rinne
Nigral degeneration in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1993;8 Suppl 1():S31-5.
1993: M A Päivärinta; Reijo J Marttila; Juha O Rinne; UK Rinne
Dopaminergic neurotransmission in chronic herpes simplex virus brain infection in rabbits.
Journal of neural transmission. General section 1993;93(3):205-12.
1992: A Laihinen; Juha O Rinne; UK Rinne; Merja Haaparanta; Ulla Ruotsalainen; Jörgen Bergman; Olof Solin
[18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462).
Neurology 1992;42(1):199-203.
1992: M A Päivärinta; Reijo J Marttila; Juha O Rinne; UK Rinne
Decrease in mesencephalic dopamine autoreceptors in experimental herpes simplex encephalitis.
Journal of neural transmission. General section 1992;89(1-2):71-80.
1991: Juha O Rinne; A Laihinen; P Lönnberg; P Marjamäki; UK Rinne
A post-mortem study on striatal dopamine receptors in Parkinson's disease.
Brain research 1991;556(1):117-22.
1991: Juha O Rinne; M Röyttä; L Paljärvi; J Rummukainen; UK Rinne
Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease.
Neurology 1991;41(6):859-61.
1991: Juha O Rinne; T Myllykylä; P Lönnberg; P Marjamäki
A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease.
Brain research 1991;547(1):167-70.
1991: Juha O Rinne
Nigral degeneration in Parkinson's disease in relation to clinical features.
Acta neurologica Scandinavica. Supplementum 1991;136():87-90.
1991: Juha O Rinne; A Laihinen; Kjell Någren; Jörgen Bergman; Merja Haaparanta; Olof Solin; Ulla Ruotsalainen; UK Rinne
Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson's disease.
Acta radiologica. Supplementum 1991;376():152.
1991: A Laihinen; Juha O Rinne; Kjell Någren; Jörgen Bergman; Merja Haaparanta; Olof Solin; Ulla Ruotsalainen; UK Rinne
Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.
Acta radiologica. Supplementum 1991;376():151.
1990: Juha O Rinne; A Laihinen; Kjell Någren; Jörgen Bergman; Olof Solin; Merja Haaparanta; Ulla Ruotsalainen; UK Rinne
PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.
Journal of neuroscience research 1990;27(4):494-9.
1990: Juha O Rinne; P Lönnberg; P Marjamäki
Age-dependent decline in human brain dopamine D1 and D2 receptors.
Brain research 1990;508(2):349-52.
1990: UK Rinne; A Laihinen; Juha O Rinne; Kjell Någren; Jörgen Bergman; Ulla Ruotsalainen
Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1990;5(1):55-9.
1989: UK Rinne; Juha O Rinne
Treatment of early Parkinson's disease with controlled-release levodopa preparations.
Neurology 1989;39(11 Suppl 2):78-81; discussion 95.
1989: Juha O Rinne; J Rummukainen; L Paljärvi; UK Rinne
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra.
Annals of neurology 1989;26(1):47-50.
1989: Juha O Rinne; P Lönnberg; P Marjamäki; UK Rinne
Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
Brain research 1989;483(2):402-6.
1989: Juha O Rinne; J Rummukainen; L Paljärvi; E Säkö; P Mölsä; UK Rinne
Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
Progress in clinical and biological research 1989;317():325-32.
1988: Juha O Rinne; T Halonen; PJ Riekkinen; UK Rinne
Free amino acids in the brain of patients with Parkinson's disease.
Neuroscience letters 1988;94(1-2):182-6.
1988: Juha O Rinne; E Säkö; L Paljärvi; P K Mölsä; UK Rinne
A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.
Journal of neural transmission 1988;73(2):121-8.
1987: P K Mölsä; E Säkö; L Paljärvi; Juha O Rinne; UK Rinne
Alzheimer's disease: neuropathological correlates of cognitive and motor disorders.
Acta neurologica Scandinavica 1987;75(6):376-84.
1987: UK Rinne; Juha O Rinne; J K Rinne; K Laakso
Chemical neurotransmission in the parkinsonian brain.
Medical biology 1987;65(2-3):75-81.
1986: Juha O Rinne; E Säkö; L Paljärvi; P K Mölsä; UK Rinne
Brain dopamine D-1 receptors in senile dementia.
Journal of the neurological sciences 1986;73(2):219-30.
1986: Juha O Rinne; E Säkö; L Paljärvi; P K Mölsä; UK Rinne
Brain dopamine D-2 receptors in senile dementia.
Journal of neural transmission 1986;65(1):51-62.
1985: Juha O Rinne; J K Rinne; K Laakso; P Lönnberg; UK Rinne
Dopamine D-1 receptors in the parkinsonian brain.
Brain research 1985;359(1-2):306-10.
1985: P K Mölsä; L Paljärvi; Juha O Rinne; UK Rinne; E Säkö
Validity of clinical diagnosis in dementia: a prospective clinicopathological study.
Journal of neurology, neurosurgery, and psychiatry 1985;48(11):1085-90.
1985: Juha O Rinne; K Laakso; P Lönnberg; P Mölsä; L Paljärvi; J K Rinne; E Säkö; UK Rinne
Brain muscarinic receptors in senile dementia.
Brain research 1985;336(1):19-25.
1984: Juha O Rinne; J K Rinne; K Laakso; L Paljärvi; UK Rinne
Reduction in muscarinic receptor binding in limbic areas of Alzheimer brain.
Journal of neurology, neurosurgery, and psychiatry 1984;47(6):651-2.
1984: UK Rinne; Juha O Rinne; J K Rinne; K Laakso; P Lönnberg
Brain neurotransmitters and neuropeptides in Parkinson's disease.
Acta physiologica et pharmacologica latinoamericana : organo de la Asociación Latinoamericana de Ciencias Fisiológicas y de la Asociación Latinoamericana de Farmacología 1984;34(3):287-99.
1983: UK Rinne; J K Rinne; Juha O Rinne; K Laakso; Olli Tenovuo; P Lönnberg; V Koskinen
Brain enkephalin receptors in Parkinson's disease.
Journal of neural transmission. Supplementum 1983;19():163-71.
1983: UK Rinne; Juha O Rinne; J K Rinne; K Laakso; A Laihinen; P Lönnberg
Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.
Journal of neural transmission. Supplementum 1983;18():279-86.